Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06266520
Status:
RECRUITING
Last Update Posted:
2024-02-20
First Post:
2024-02-06
Brief Title:
MNK Therapy in Releasing the Superficial Fascia for Patients With AAS an Assessor-blinded Randomised Controlled Trial
Sponsor:
Sen-wei Lu
Organization:
Affiliated Dongyang Hospital of Wenzhou Medical University
Study Overview
Official Title:
Micro-needle-knife Therapy in Releasing the Superficial Fascia for Patients With Acute Ankle Sprain an Assessor-blinded Randomised Controlled Trial
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this type of randomized controlled trial employing a blinded evaluator methodology to verify the clinical efficacy and safety of MNK therapy This aims to provide a reference for clinical practitioners and AAS patients in their decision-making process
Participants will randomly allocated into two groups using a random number table method with forty patients in each group The experimental group Group 1 underwent MNK therapy to release the superficial fascia while the control group Group 2 received conventional acupuncture treatment
Participants will randomly allocated into two groups using a random number table method with forty patients in each group The experimental group Group 1 underwent MNK therapy to release the superficial fascia while the control group Group 2 received conventional acupuncture treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None